Progesterone and autoimmune disease

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Hughes, Grant C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoimmunity; Progesterone; Sex hormones; Sex steroids; SLE; Systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; ANDROGEN; ESTROGEN; PROGESTERONE; PROGESTERONE RECEPTOR; SEX HORMONE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BASOPHIL; BIRTH CONTROL; CD4+ T LYMPHOCYTE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EOSINOPHIL; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOMODULATION; MACROPHAGE; MAST CELL; MULTIPLE SCLEROSIS; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NEUTROPHIL; PLASMACYTOID DENDRITIC CELL; PREGNANCY; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH17 CELL; THYROID DISEASE;

AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; PREGNANCY; PROGESTERONE; PROGESTINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84858439656     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.12.003     Document Type: Review

References (184)

1. Baker M.E. Origin and diversification of steroids: co-evolution of enzymes and nuclear receptors. Mol Cell Endocrinol 2011, 334:14-20.
2. Danilova N. The evolution of immune mechanisms. J Exp Zool B Mol Dev Evol 2006, 306:496-520.
3. Billington W.D. The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J Reprod Immunol 2003, 60:1-11.
4. McCombe P., Greer J., Mackay I. Sexual dimorphism in autoimmune disease. Curr Mol Med 2009, 9:1058-1079.
5. Gabbe S.G., Niebyl J.R., Simpson J.L. Obstetrics: Normal and Problem Pregnancies 2007, Churchill Linvingstone, Philadelphia, PA. 5th ed.
6. Pluchino N., Cubeddu A., Giannini A., Merlini S., Cela V., Angioni S., et al. Progestogens and brain: an update. Maturitas 2009, 62:349-355.
7. Schneider J., Burgess C., Sleiter N., DonCarlos L., Lydon J., O'Malley B., et al. Enhanced sexual behaviors and androgen receptor immunoreactivity in the male progesterone receptor knockout mouse. Endocrinology 2005, 146:4340-4348.
8. Scofield R.H. Genetics of systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 2009, 21:448-453.
9. Adams K.A., Nelson J.L. Michrochimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2009, 291:1127-1131.
10. Milo R., Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010, 9:A387-A394.
11. Chervonsky A.V. Influence of microbial environment on autoimmunity. Nat Immunol 2010, 11:28-35.
12. Biro F.M., Huang B., Crawford P.B., Lucky A.W., Striegel-Moore R., Barton B.A., et al. Pubertal correlates in black and white girls. J Pediatr 2006, 148:234-240.
13. Zink A., Listing J., Klindworth C., Zeidler H., Centres G.C.A. The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients. Ann Rheum Dis 2001, 60:199-206.
14. Weckerle C.E., Niewold T.B. The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies. Clin Rev Allergy Immunol 2011, 40:42-49.
15. Lahita R. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999, 11:352-356.
16. Kamphuis S., Silverman E.D. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol 2010, 6:538-546.
17. Pluchinotta F.R., Schiavo B., Vittadello F., Martini G., Perilongo G., Zulian F. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Lupus 2007, 16:550-555.
18. Mariotti S., Prinzis A., Ghiani M., Cambuli V.M., Pilia S., Marras V., et al. Puberty is associated with a marked increase of the female sex predominance in chronic autoimmune thyroiditis. Horm Res 2009, 72:52-56.
19. Civilibal M., Canpolat N., Yurt A., Kurugoglu S., Erdamar S., Bagci O., et al. A child with primary Sjogren syndrome and a review of the literature. Clin Pediatr (Phila) 2007, 46:738-742.
20. Dahlan Y., Smith L., Simmonds D., Jewell L.D., Wanless I., Heathcote E.J., et al. Pediatric-onset primary biliary cirrhosis. Gastroenterology 2003, 125:1476-1479.
21. Ober C., Loisel D.A., Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet 2008, 9:911-922.
22. Gonzalez D.A., Diaz B.B., Rodriguez Perez M.del C., Hernandez A.G., Chico B.N., de Leon A.C. Sex hormones and autoimmunity. Immunol Lett 2010, 133:6-13.
23. Martocchia A., Stefanelli M., Cola S., Falaschi P. Sex steroids in autoimmune diseases. Curr Top Med Chem 2011, 11:1668-1683.
24. Arason G.J., Jorgensen G.H., Ludviksson B.R. Primary immunodeficiency and autoimmunity: lessons from human diseases. Scand J Immunol 2010, 71:317-328.
25. Harley I., Kaufman K., Langefield C., Harley J., Kelly J. Genetic susceptibility to SLE: new insights form fine mapping and genome-wide association studies. Nat Rev Genet 2009, 10:285-290.
26. Moser K., Kelly J., Lessard C., Harley J. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009, 10:373-379.
27. Al-Mayouf S.M., Abanomi H., Eldali A. Impact of C1q deficiency on the severity and outcome of childhood systemic lupus erythematosus. Int J Rheum Dis 2011, 14:81-85.
28. Manderson A.P., Botto M., Walport M.J. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004, 22:431-456.
29. Shaw E.A., Stevens A.M. Are pediatric autoimmune diseases primarily genetic diseases. Curr Opin Rheumatol 2008, 20:589-594.
30. Hughes T., Adler A., Merrill J.T., kelly J.A., Kaufman K., Williams A., et al. Sex-Specific Genetic Architecture of Systemic Lupus Erythematosus. Poster session presented at: The American College of Rheumatology Annual Scientific Meeting November 6 2011, Chicago, IL, USA.
31. Wallace D.J., Hahn B.H. Dubois' Lupus Erythematosus 2007, Lippincott Williams & Wilkins, Philadelphia, PA. 7th ed.
32. Richez C., Barnetche T., Miceli-Richard C., Blanco P., Moreau J.F., Rifkin I., et al. Role for interferon regulatory factors in autoimmunity. Joint Bone Spine 2010, 77:525-531.
33. Hindorff L.A., MacArthur J., Wise A., Junkins H.A., Hall P.N., Klemm A.K., et al. A catolog of published genome-wide association studies Available at:. http://www.genome.gov/gwastudies.
34. Korman B.D., Kastner D.L., Gregersen P.K., Remmers E.F. STAT4: Genetics, Mechanisms, and Implications for Autoimmunity. Curr Allergy Asthma Rep 2008, 8:398-403.
35. Shen N., Fu Q., Deng Y., Qian X., Zhao J., Kaufman K.M., et al. Sex-specific assoctiation of X-linked toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A 2010, 107:15838-15843.
36. Han S., Guthridge J.M., Harley I.T.W., Sestak A.L., Kim-Howard X., Kaufman K.M., et al. Osteopontin and Systemic Lupus Erythematosus Association: A Probable Gene-Gender Interaction. PLoS One 2008, 3:e0001757. 10.1371/journal.pone.
37. Groves C.J., Howells R.D., Williams S., Darke C., Parkes A. Primary standardization for the ELISA of serum thyroperoxidase and thyroglobulin antibodies and their prevalence in a normal Welsh population. J Clin Lab Immunol 1990, 32:147-151.
38. Klareskog L., Padyukov L., Ronnelid J., Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 2006, 18:650-655.
39. Arbuckle M., McClain M., Rubertone M., Scofield R., Dennis G., James J., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 16:1526-1533.
40. Deng Y., Tsao B.P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 2010, 6:683-692.
41. Bagavant H., Fu S.M. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol 2009, 21:489-494.
42. Ostensen M., Villiger P.M. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol 2007, 29:185-191.
43. Kelder J., Azevedo R., Pang Y., Vlieg Jd, Dong J., Thomas P. Comparison between steroid binding to membrane progesterone receptor alpha(mPRalpha) and to nuclear progesterone receptor: Correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-specific agonists. Steroids 2010, 75:314-322.
44. Thomas P. Characteristics of membrane progestin receptor alpha (mPR-alpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol 2008, 29:292-312.
45. Dressing G.E., Goldberg J.E., Charles N.J., Schwertfeger K.L., Lange C.A. Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications. Steroids 2011, 76:11-17.
46. Schindler A.E., Campagnoli C., Druckmann R., Huber J., Pasqalini J.R., Schweppe K.W., et al. Reprint of classification and pharmacology of progestins. Maturitas 2008, 61:171-180.
47. Flammer J.R., Rogatsky I. Minireview: Glucocorticoids in Autoimmunity: Unexpected Targets and Mechanisms. Mol Endocrinol 2011, 25:1075-1086.
48. Hel Z., Stringer E., Mestecky J. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev 2010, 31:79-97.
49. Morrison C., Turner A., Jones L. Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 2009, 23:263-284.
50. Africander D., Verhoog N., Hapgood J. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Steroids 2011, 76:636-652.
51. Clark R. Glucocorticoid receptor antagonists. Curr Top Med Chem 2008, 8:813-838.
52. Gilliver S.C. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 2010, 120:105-115.
53. Dosiou C., Hamilton A., Pang Y., Overgaard M., Tulac S., Dong J., et al. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol 2008, 196:67-77.
54. Tibbetts T., DeMayo F., Rich S., Conneely O.M., O'Malley B. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci U S A 1999, 96:12021-12026.
55. Poole J.A., Claman H.N. Immunology of pregnancy: implications for the mother. Clin Rev Allergy Immunol 2004, 26:161-170.
56. Munoz-Suano A., Hamilton A., Betz A. Gimme shelter: the immune system during pregnancy. Immunol Rev 2011, 241:20-38.
57. Kwak-Kim J., Gilman-Sachs A. Clinical implication of natural killer cells and reproduction. Am J Reprod Immunol 2008, 59:388-400.
58. Collins M.K., Tay C.S., Erlebacher A. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J Clin Invest 2009, 119:2062-2073.
59. Saito S., Nakashima A., Shima T., Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010, 63:601-610.
60. Szekeres-Bartho J., Polgar B. PIBF: The Double Edged Sword. Pregnancy and Tumor. Am J Reprod Immunol 2010, 64:77-86.
61. Alok A., Karande A.A. The role of glycodelin as an immune-modulating agent at the feto-maternal interface. J Reprod Immunol 2009, 83:124-127.
62. Shet A. Congenital and perinatal infections: throwing new light with and old TORCH. Indian J Pediatr 2011, 78:88-95.
63. Fainboim L., Arruvito L. Mechanisms involved in the expansion of Tregs during pregnancy: role of IL-2/STAT5 signalling. J Reprod Immunol 2011, 88:93-98.
64. Luppi P. How immune mechanisms are affected by pregnancy. Vaccine 2003, 21:3352-3357.
65. Prados M.B., La Blunda J., Szekeres-Bartho J., Caramelo J., Miranda S. Progesterone induces a switch in oligosaccharyltransferase isoform expression: consequences on IgG N-glycosylation. Immunol Lett 2011, 137:28-37.
66. Hince M., Sakkal S., Vlahos K., Dudakov J., Boyd R., Chidgey A. The role of sex steroids and gonadectomy in the control of thymic involution. Cell Immunol 2008, 252:122-138.
67. Kincade P.W., Medina K.L., Payne K.J., Rossi M.I.D., Tudor K.R.S., Yamashita Y., et al. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev 2000, 175:128-137.
68. Hughes G.C., Thomas S., Li C., Kaja M., Clark E.A. Progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J Immunol 2008, 180:2029-2033.
69. Tibbetts T., Conneely O., O'Malley B. Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol Reprod 1999, 60:1158-1165.
70. Hughes G.C., Martin D., Zhang K., Hudkins K.L., Alpers C.E., Clark E.A., et al. Decrease in Glomerulonephritis and Th1-Associated Autoantibody Production After Progesterone Treatment in NZB/NZW Mice. Arthritis Rheum 2009, 60:1775-1784.
71. Hughes G.C., Clark E.A. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity 2007, 40:470-481.
72. Pauklin S., Sernandez I., Bachmann G., Ramiro A., Petersen-Mahrt S. Estrogen directly activates AID transcription and function. J Exp Med 2009, 206:99-111.
73. Munoz-Cruz S., Togno-Pierce C., Morales-Montor J. Non-reproductive effects of sex steroids: their immunoregulatory role. Curr Top Med Chem 2011, 11:1714-1727.
74. Gallery E., Raftos J., Gyory A., Wells J. A prospective study of serum complement (C3 and C4) levels in normal human pregnancy: effect of the development of pregnancy-associated hypertension. Aust N Z J Med 1981, 11:243-245.
75. Karina R., Soto E., Romero R., Espinoza J., Chaiworapongsa T., Nien J., et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 2005, 17:239-245.
76. Yilmazer M., Fenkci V., Fenkci S., Aktepe O., Sonmezer M., Kurtay G. Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy post-menopausal women. Hum Reprod 2003, 18:1531-1535.
77. Meroni P.L., Borghi M.O., Raschi E., Tedesco F. Pathogenesis of the antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011, 7:330-339.
78. Bouman A., Heineman M., Faas M. Sex hormones and the immune response in humans. Hum Reprod Update 2005, 4:411-423.
79. Warde N. Autoimmunity: the role of neutrophils in SLE: untangling the NET. Nat Rev Rheumatol 2011, 7:252.
80. Lamprecht P., Holle J., Gross W. Update on clinical, pathophysiological and therapeutic aspects in ANCA-associated vasculitis. Curr Drug Discov Technol 2009, 6:241-251.
81. Chen W., Mempel M., Schober W., Behrendt H., Ring J. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 2008, 63:1418-1427.
82. Hamano N., Terada N., Maesako K., Numata T., Konno A. Effect of sex hormones on eosinophilic inflammation in nasal mucosa. Allergy Asthma Proc 1998, 19:263-269.
83. Grunert G., Porcia M., Neumann G., Sepulveda S., Tchermitchin A.N. Progesterone interaction with eosinophils and with responses already induced by oestrogen in the uterus. J Endocrinol 1984, 102:295-303.
84. Padilla L., Reinicke K., Montesino H., Villena F., Asencio H., Cruz M., et al. Histamine content and mast cells distribution in mouse uterus: the effect of sexual hormones, gestation and labor. Cell Mol Biol 1990, 36:93-100.
85. Schroeder J.T. Basophils: emerging roles in the pathogenesis of allergic disease. Immunol Rev 2011, 242:144-160.
86. Murphy K., Travers P., Walport M. Janeway's Immunobiology 2008, Garland Science, New York and London. 7th ed.
87. Manaster I., Mandelboim O. The unique properties of uterine NK cells. Am J Reprod Immunol 2010, 63:434-444.
88. Carosella E.D., Gregori S., Rouas-Freiss N., LeMaoult J., Menier C., Favier B. The role of HLA-G in immunity and hematopoiesis. Cell Mol Life Sci 2011, 68:353-368.
89. Szekeres-Bartho J., Halasz M., Pakovics T. Progesterone in pregnancy; receptor-ligand interaction and signaling pathways. J Reprod Immunol 2009, 83:60-64.
90. Arruvito L., Giulianelli S., Flores A., Paladino N., Barboza M., Lanari C., et al. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol 2008, 180:5746-5753.
91. Manuck T., Major H., Varner M., Chettier R., Nelson L., Esplin M. Progesterone receptor genotype, family hisotry, and spontaneous preterm birth. Obstet Gynecol 2010, 115:765-770.
92. Su M.T., Lee I.W., Chen Y.C., Kuo P.L. Association of progesterone receptor polymorphism with idiopathic recurrent pregnancy loss in Taiwanese Han population. J Assist Reprod Genet 2011, 28:239-243.
93. Nagamatsu T., Schust D.J. The contribution of macrophages to normal and pathological pregnancies. Am J Reprod Immunol 2010, 63:460-471.
94. Hunt J.S., Miller L., Platt J.S. Hormonal Regulation of Uterine Macrophages. Dev Immunol 1998, 6:105-110.
95. Pisetsky D.S., Spencer D.M. Effects of progesterone and estradiol sex hormones on the release of microparticles by RAW 264.7 macrophages stimulated by Poly(I:C). Clin Vaccine Immunol 2011, 18:1420-1426.
96. Chao T., Chao H., Chen M., Greager J.A., Walter R.J. Female sex hormones modulate the function of LPS-treated macrophages. Am J Reprod Immunol 2000, 44.
97. Gomez F., Ruiz P., Briceno F., Lopez R., Michan A. Treatment with progesterone analogues decreases macrophage Fc-gamma receptors expression. Clin Immunol Immunopathol 1998, 89:231-239.
98. Schreiber A.D., Nettl F.M., Sanders M.C., King M., Szabolcs P., Friedman D., et al. Effect of endogenous and synthetic sex steroids on the clearance of antibody-coated cells. J Immunol 1988, 141:2959-2966.
99. Peng Y., Martin D.A., Kenkel J., Zhang K., Ogden C.A., Elkon K.B. Innate and adaptive immune response to apoptotic cells. J Autoimmun 2007, 29:303-309.
100. Butts C., Shukair S., Duncan K., Bowers E., Horn C., Belyavskaya E., et al. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int Immunol 2007, 19:287-296.
101. Kyurkchiev D., Ivanova-Todorova E., Hayrabedyan S., Altankova I., Kyurkchiev S. Female sex steroid hormones modify some regulatory properties of monocyte-derived dendritic cells. Am J Reprod Immunol 2007, 58:425-433.
102. Jones L.A., Kreem S., Shweash M., Paul A., Alexander J., Roberts C.W. Differential modulation of TLR3- and TLR4-mediated dendritic cell maturation and function by progesterone. J Immunol 2010, 185:4525-4534.
103. Elkon K.B., Stone V.V. Type I interferon and systemic lupus erythematosus. J Interferon Cytokine Res 2011, 31:803-812.
104. Berghofer B., Frommer T., Haley G., Fink L., Bein G., Hacktein H. TLR7 ligands induce higher IFN-alpha production in females. J Immunol 2006, 177:2088-2096.
105. Meier A., Chang J.J., Chan E.S., Pollard R.B., Sidhu H.K., Kulkarni S., et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009, 15:955-959.
106. Baudino L., Silveira SAd, Nakata M., Izui S. Molecular and cellular basis for pathogenecity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer Semin Immunopathol 2006, 28:175-184.
107. Menzies F., Henriquez F. Immunomodulation by the female sex steroids. Open Infect Dis J 2009, 3:61-72.
108. Correale J., Arias M., Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998, 161:3365-3374.
109. Piccinini M., Giudizi M., Biagiotti R. Progesterone favors the development of human T helper cells producing Th2-type cytokines and pormotes both IL-4 production and membrane CD30 expression in established Th1 clones. J Immunol 1995, 155:128-133.
110. Miyaura H., Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002, 168:1087-1094.
111. Karpuzoglu E., Phillips R.A., Gogal R.M. Ansar Ahmed S. IFN-gamma-inducing transcription factor, T-bet is upregulated by estrogen in murine splenocytes: role of IL-27 but not IL-12. Mol Immunol 2007, 44:1808-1814.
112. Kozma N., Halasz M., Polgar B., Poehlmann T., Markert U., Palkovics T., et al. Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor. J Immunol 2006, 176:819-826.
113. Karpuzoglu E., Phillips R.A., Dai R., Graniello C., Gogal R.M., Ahmed S.A. Signal transducer and activation of transcription (STAT) 4beta, a shorter isoform of interleukin-12-induced STAT4, is preferentially activated by estrogen. Endocrinology 2009, 150:1310-1320.
114. Aluvihare V., Betz A. The role of regulatory T cells in alloantigen tolerance. Immunol Rev 2006, 212:330-343.
115. Lee J., Ulrich B., Cho J., Park J., Kim C. Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells. J Immunol 2011, 187:1778-1787.
116. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery C.A., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995, 9:2266-2278.
117. Strioga M., Pasukoniene V., Characiejus D. CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology 2011, 134:17-32.
118. White H., Crassi K., Givan A., Stern J., Gonzales J., Memoli V., et al. CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol 1997, 158:3017-3027.
119. Soni C., Karande A.A. Glycodelin A suppresses the cytolytic activity of CD8+ T lymphocytes. Mol Immunol 2010, 47:2458-2466.
120. + Cells Abolishes the Pregnancy Protective Effect of Progesterone Substitution with Dydrogesterone in Mice by Altering the Th1/Th2 Cytokine Profile1. J Immunol 2004, 172:5893-5899.
121. Hall N. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?. Obstet Gynecol Clin North Am 2011, 38:235-246.
122. + T Cell Viral-Specific Effector Function and Induces Herpes Simplex Virus Type 1 Reactivation. J Immunol 2008, 181:969-975.
123. Medina K.L., Kincade P.W. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci U S A 1994, 91:5382-5386.
124. Vermeulen M., Pazos P., Lanari C., Molinolo A., Bamberale R., Geffner J., et al. Medroxyprogesterone acetate enahances in vivo and in vitro antibody production. Immunology 2001, 104:80-86.
125. Pauklin S., Petersen-Mahrt S. Progesterone inhibits activation-induced deaminase by binding to the promoter. J Immunol 2009, 183:1238-1244.
126. Arnold J.N., Wormald M.R., Sim R.B., Rudd P.M., Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 2007, 25:21-50.
127. Parekh R., Roitt I., Isenberg D., Dwek R., Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 1988, 167:1731-1736.
128. Rook G.A.W., Steele J., Brealy R., Whyte A., Isenberg D., Sumar N., et al. Changes in IgG Glycoform Levels are Associated with Remission of Arthritis During Pregnancy. J Autoimmun 1991, 4:779-794.
129. Riboldi E., Daniele R., Parola C., Inforzato A., Arnold P.L., Bosisio D., et al. Human C-type Lectin Domain Family 4, Member C (CLEC4C/BDCA-2/CD303) Is a Receptor for Asialo-galactosyl-oligosaccharides. J Biol Chem 2011, 286:35329-35333.
130. Costenbader K., Feskanich D., Stampfer M., Karlson E. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 2007, 56:1251-1262.
131. Bernier M., Mikaeloff Y., Hudson M., Suissa S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum 2009, 61:476-481.
132. Petri M., Thompson E., Abusuwwa R., Huang J., Garrett E. BALES: the Baltimore lupus environmental study [abstract]. Arthritis Rheum 2001, 44:S331.
133. Medeiros P.B., Febronio M.V., Bonfa E., Borba E.F., Takiuti A.S., Silva C.A.A. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus 2009, 18:38-43.
134. Verma S., Ismail A., Gao X., Fu G., Li Z., O'Malley B., et al. The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors. Mol Cell Biol 2004, 24:8716-8726.
135. Steward M., Hay F. Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice. Clin Exp Immunol 1976, 26:363-370.
136. Talal N. Natural history of murine lupus. Modulation by sex hormones. Arthritis Rheum 1978, 21:S58-S63.
137. Keisler L., Kier A., Walker S. Effects of prolonged adminstration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogesterone and ehtinyl estradiol. Autoimmunity 1991, 9:21-32.
138. Roubinian J., Talal N., Siiteri P., Sadakian J. Sex hormone modulation of autoimmunity in NZB/W mice. Arthritis Rheum 1979, 22:1162-1169.
139. Borchers A.T., Naguwa S.M., Keen C.L., Gershwin M.E. The implications of autoimmunity and pregnancy. J Autoimmun 2010, 34:J287-J299.
140. Clowse M.E.B. Lupus Activity in Pregnancy. Rheum Dis Clin North Am 2007, 33:237-252.
141. Culwell K.R., Curtis K.M., Cravioto MdC Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review. Obstet Gynecol 2009, 114:341-353.
142. Holroyd C.R., Edwards C.J. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus. Climacteric 2009, 12:378-386.
143. Vieira C.S., Vasconcelos G., Sa MFSd, Junior P.L., Martins W.P., Ferriani R.A. Tibolone in postmenopausal women with systemic lupus erythematosus: A pilot study. Maturitas 2008, 62:311-316.
144. Chabbert-Buffet N., Amoura Z., Scarabin P., Frances C., Levy D.P., Galicier L., et al. Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients. Contraception 2011, 83:229-237.
145. Klippel J.H., Stone J.H., Crofford L.J., White P.H. Primer on the rheumatic diseases 2008, Springer, New York, NY. 13th ed.
146. Guthrie K.A., Dugowson C.E., Voigt L.F., Koepsell T.D., Nelson J.L. Does pregnancy provide vaccine-like protection against rheumatoid arthritis?. Arthritis Rheum 2010, NA-NA.
147. Liao K.P., Alfredsson L., Karlson E.W. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009, 21:279-283.
148. Ganesan K., Balachandran C., Manohar B., Puvanakrishnan R. Comparative studies on the interplay of testosterone, estrogen and progesterone in collagen induced arthritis in rats. Bone 2009, 43:758-765.
149. Subramanian S., Tovey M., Afentoulis M., Krogstad A., Vandenbark A.A., Offner H. Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta. Clin Immunol 2005, 115:162-172.
150. Islander U., Jochems C., Lagerquist M.K., Forsblad-d'Elia H., Carlsten H. Estrogen in rheumatoid arthritis; the immune system and bone. Mol Cell Endocrinol 2011, 335:14-29.
151. Jochems C., Islander U., Erlandsson M., Engdahl C., Lagerquist M., Ohlsson C., et al. Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis. Clin Exp Immunol 2011, 165:121-129.
152. Moro M., Bjornsson J., Marietta E., Hofmeister E., Germer J., Bruinsma E., et al. Gestational attenuation of lyme arthritis is mediated by progesterone and IL-4. J Immunol 2001, 166:7404-7409.
153. Waites G.T., Whyte A. Effect of pregnancy on collagen-induced arthritis in mice. Clin Exp Immunol 1987, 67.
154. Jadidi-Niaragh F., Mirshafiey A. Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis. Scand J Immunol 2011, 74:1-13.
155. Alonso A., Clark C.J. Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence. J Neurol Sci 2009, 286:73-75.
156. El-Etr M., Ghoumari A., Sitruk-Ware R., Schumacher M. Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids. Maturitas 2011, 68:47-51.
157. Jorgensen K.T., Pedersen B.V., Nielsen N.M., Jacobsen S., Frisch M. Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmun 2011, [Epub ahead of print].
158. Lelu K., Laffont S., Delpy L., Paulet P.E., Perinat T., Tschanz S.A., et al. Estrogen receptor alpha signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol 2011, 187:2386-2393.
159. Garay L., Deniselle M.C., Meyer M., Costa J.J., Lima A., Roig P., et al. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis. Brain Res 2009, 1283:177-185.
160. Hoffman G.E., Le W.W., Murphy A.Z., Koski C.L. Divergent Effects of Ovarian Steroids on Neuronal Survival during Experimental Allergic Encephalitis in Lewis Rats. Exp Neurol 2001, 171:272-284.
161. Hughes M.D. Multiple sclerosis and pregnancy. Neurol Clin 2004, 22:757-769.
162. Yu H.J., Fei J., Chen X.S., Cai Q.Y., Liu H.L., Liu G.D., et al. Progesterone attenuates neurological behavioral deficits of experimental autoimmune encephalomyelitis through remyelination with nucleus-sublocalized Olig1 protein. Neurosci Lett 2010, 476:42-45.
163. Liu M., Kelley M.H., Herson P.S., Hurn P.D. Neuroprotection of sex steroids. Minerva Endocrinol 2010, 35:127-143.
164. Yates M.A., Li Y., Chlebeck P., Proctor T., Vandenbark A.A., Offner H. Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J Neuroimmunol 2010, 220:136-139.
165. Vukusic S., Ionescu I., El-Etr M., Schumacher M., Baulieu E.E., Cornu C., et al. The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: Rationale, objectives and state of advancement. J Neurol Sci 2009, 286:114-118.
166. Melmed S., Polonsky K.S., Larsen P.R.M.D., Kronenberg H.M. Williams Textbook of Endocrinology 2012, Saunders, St. Louis, MO. 12 ed.
167. Strieder T.G.A., Prummel M.F., Tijssen J.G.P., Endert E., Wiersinga W.M. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) 2003, 59:396-401.
168. Greer L.G., Casey B.M., Halvorson L.M., Spong C.Y., McIntire D.D., Cunningham F.G. Antithyroid antibodies and parity: further evidence for microchimerism in autoimmune thyroid disease. Am J Obstet Gynecol 2011, 205(5):471.e1-4.
169. Ahmed S.A., Young P.R., Penhale W.J. The effects of female sex steroids on the development of autoimmune thyroidits in thymectomized and irradiated rats. Clin Exp Immunol 1983, 54:351-358.
170. Caturegli P., Kuppers R.C., Mariotti S., Burek C.L., Pinchera A. IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin Exp Immunol 1994, 98:464-469.
171. Zuniga R., Markowitz G.S., Arkachaisri T., Imperatore E.A., D'Agati V.D., Salmon J.E. Identification of IgG subclasses and C-reactive protein in lupus nephritis. Arthritis Rheum 2003, 48:460-470.
172. Jefferis R., Kumararatne D. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol 1990, 81:357-367.
173. Weetman A.P. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat Rev Endocrinol 2010, 6:311-318.
174. Beeson P.B. Age and sex association of 40 autoimmune diseases. Am J Med 1994, 96:457-462.
175. Cooper G.S., Stroehla B.C. The epidemiology of autoimmune diseases. Autoimmun Rev 2003, 2:119-125.
176. Porola P., Laine M., Virkki L., Poduval P., Konttinen Y.T. The Influence of Sex Steroids on Sjogren's Syndrome. Ann N Y Acad Sci 2007, 1108:426-432.
177. Suzuki T., Schaumberg D.A., Sullivan B.D., Liu M., Richards S.M., Sullivan R.M., et al. Do Estrogen and Progesterone Play a Role in the Dry Eye of Sjögren's Syndrome?. Ann N Y Acad Sci 2002, 966:223-225.
178. Oliver J.E., Silman A.J. Why are women predisposed to autoimmune rheumatic diseases?. Arthritis Res Ther 2009, 11:252.
179. Pisa F.E., Bovenzi M., Romeo L., Tonello A., Biasi D., Bambara L.M., et al. Reproductive factors and the risk of scleroderma: an Italian case-control study. Arthritis Rheum 2002, 46:451-456.
180. Corpechot C., Chretien Y., Chazouilleres O., Poupon R. Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 2010, 53:162-169.
181. Boone R.H., Cheung A.M., Girlan L.M., Heathcote E.J. Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin. Dig Dis Sci 2006, 51:1103-1112.
182. Omarsdottir S., Hallmin H., Naessen T., Petren-Mallmin M., Broome U., Hultcrantz R., et al. An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis. J Intern Med 2004, 256:63-69.
183. Savolainen E., Miettinen T.A., Pikkarainen P., Salaspuro M.P., Kivirikko K.I. Enzymes of collagen synthesis and type III procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary biliary cirrhosis. Gut 1983, 24:136-142.
184. Whitacre C. Sex differences in autoimmune disease. Nat Immunol 2001, 2:777-780.